Rheumatoid Arthritis (RA) Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014661121
Market Monitor Global
Dec-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Rheumatoid Arthritis (RA) Drugs in Global, including the following market information:
Global Rheumatoid Arthritis (RA) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Rheumatoid Arthritis (RA) Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Rheumatoid Arthritis (RA) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis (RA) Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, By Type, 2020 (%)
NSAIDs
Analgesic Drugs
Corticosteroids
DMARDs
Biological Therapies
JAK-inhibitors

China Rheumatoid Arthritis (RA) Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others

Global Rheumatoid Arthritis (RA) Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Rheumatoid Arthritis (RA) Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Rheumatoid Arthritis (RA) Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Rheumatoid Arthritis (RA) Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Rheumatoid Arthritis (RA) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatoid Arthritis (RA) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatoid Arthritis (RA) Drugs Overall Market Size
2.1 Global Rheumatoid Arthritis (RA) Drugs Market Size: 2021 VS 2027
2.2 Global Rheumatoid Arthritis (RA) Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatoid Arthritis (RA) Drugs Players in Global Market
3.2 Top Global Rheumatoid Arthritis (RA) Drugs Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis (RA) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Rheumatoid Arthritis (RA) Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Rheumatoid Arthritis (RA) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Rheumatoid Arthritis (RA) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis (RA) Drugs Market Size Markets, 2021 & 2027
4.1.2 NSAIDs
4.1.3 Analgesic Drugs
4.1.4 Corticosteroids
4.1.5 DMARDs
4.1.6 Biological Therapies
4.1.7 JAK-inhibitors
4.2 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2021
4.2.2 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2022-2027
4.2.3 By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis (RA) Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2021
5.2.2 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2022-2027
5.2.3 By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Rheumatoid Arthritis (RA) Drugs Market Size, 2021 & 2027
6.2 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2021
6.2.2 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue, 2022-2027
6.2.3 By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2027
6.3.2 US Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.3.3 Canada Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.3.4 Mexico Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2027
6.4.2 Germany Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4.3 France Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4.4 U.K. Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4.5 Italy Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4.6 Russia Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.4.8 Benelux Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2027
6.5.2 China Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.5.3 Japan Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.5.4 South Korea Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.5.6 India Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2027
6.6.2 Brazil Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.6.3 Argentina Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2027
6.7.2 Turkey Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.7.3 Israel Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
6.7.5 UAE Rheumatoid Arthritis (RA) Drugs Market Size, 2016-2027
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.1.4 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.1.5 AbbVie Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.2.4 Roche Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.3.4 Merck Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 HEYL Chemisch-pharmazeutische Fabrik
7.4.1 HEYL Chemisch-pharmazeutische Fabrik Corporate Summary
7.4.2 HEYL Chemisch-pharmazeutische Fabrik Business Overview
7.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.4.4 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.4.5 HEYL Chemisch-pharmazeutische Fabrik Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.5.4 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Corporate Summary
7.6.2 Amgen, Inc. Business Overview
7.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.6.4 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.6.5 Amgen, Inc. Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.4.4 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.7.5 Pfizer Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.8.5 Bristol-Myers Squibb Key News
7.9 UCB
7.9.1 UCB Corporate Summary
7.9.2 UCB Business Overview
7.9.3 UCB Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.9.4 UCB Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.9.5 UCB Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.10.4 GSK Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.10.5 GSK Key News
7.11 Sanofi
7.11.1 Sanofi Corporate Summary
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.11.4 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.11.5 Sanofi Key News
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Corporate Summary
7.12.2 Abbott Laboratories Business Overview
7.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.12.4 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.12.5 Abbott Laboratories Key News
7.13 Teva Pharmaceutical
7.13.1 Teva Pharmaceutical Corporate Summary
7.13.2 Teva Pharmaceutical Business Overview
7.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Major Product Offerings
7.13.4 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue in Global (2016-2021)
7.13.5 Teva Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Rheumatoid Arthritis (RA) Drugs Market Opportunities & Trends in Global Market
Table 2. Rheumatoid Arthritis (RA) Drugs Market Drivers in Global Market
Table 3. Rheumatoid Arthritis (RA) Drugs Market Restraints in Global Market
Table 4. Key Players of Rheumatoid Arthritis (RA) Drugs in Global Market
Table 5. Top Rheumatoid Arthritis (RA) Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Rheumatoid Arthritis (RA) Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Rheumatoid Arthritis (RA) Drugs Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis (RA) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Rheumatoid Arthritis (RA) Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2022-2027
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 32. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Roche Corporate Summary
Table 34. Roche Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 35. Roche Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Merck Corporate Summary
Table 37. Merck Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 38. Merck Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 39. HEYL Chemisch-pharmazeutische Fabrik Corporate Summary
Table 40. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 41. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 44. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Amgen, Inc. Corporate Summary
Table 46. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 47. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 50. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 53. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 54. UCB Corporate Summary
Table 55. UCB Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 56. UCB Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 57. GSK Corporate Summary
Table 58. GSK Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 59. GSK Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 62. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 63. Abbott Laboratories Corporate Summary
Table 64. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 65. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
Table 66. Teva Pharmaceutical Corporate Summary
Table 67. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product Offerings
Table 68. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Rheumatoid Arthritis (RA) Drugs Segment by Type
Figure 2. Rheumatoid Arthritis (RA) Drugs Segment by Application
Figure 3. Global Rheumatoid Arthritis (RA) Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis (RA) Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis (RA) Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis (RA) Drugs Revenue in 2020
Figure 8. By Type - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 12. US Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 24. China Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Rheumatoid Arthritis (RA) Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Roche Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merck Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. UCB Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. GSK Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE